Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial

作者：Zheng Wang, Lixing Li, Peiran Huang, Hai‐Yan Tu, Xiangyu Zhang, Yu Lei, Fei Liang, Cheng Huang, Shuang–Jian Qiu, Qing‐Hai Ye, Zhen‐Bin Ding, Xiaowu Huang, Ying–Hong Shi, Kang Won Song, Hui‐Chuan Sun, Xiaoying Wang, Yongfeng Xu, Yu Yao, Qiang Gao, Lan Zhang, Jia Fan, Jian Zhou · 发表于：˜The œLancet. Gastroenterology & hepatology · 年份：2025 · DOI：10.1016/s2468-1253(25)00268-7 · 被引用次数：6 · 研究领域：Cholangiocarcinoma and Gallbladder Cancer Studies、Gallbladder and Bile Duct Disorders、Liver Diseases and Immunity